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Dichotomous Engagement Of Hdac3 Catalytic Activity Governs Inflammatory 
Responses 
Abstract 
Mammalian gene expression is activated by histone acetylation, which is reversed by histone 
deacetylases (HDACs) whose enzymatic functions are pharmaceutically targeted by HDAC inhibitors for 
cancer treatment and many other diseases. In addition to activating gene expression as predicted from 
their effects on the epigenome, HDAC inhibitors also silence transcription which is hard to understand 
based on current dogma. HDAC3 is particularly interesting because its enzyme activity requires 
interaction with Nuclear Receptor Corepressors (NCoR1/2). Remarkably, although global loss of HDAC3 is 
lethal owing to gastrulation defects, mice with mutations in the deacetylase-activating domains of both 
NCoR1 and NCoR2 are born in expected Mendelian ratios, despite lacking detectable HDAC3 enzymatic 
activity. These observations underlined the objective of this study, which is to elucidate the regulatory and 
physiological importance of HDAC3 non-enzymatic functions. The first aim of the study focuses on 
characterizing HDAC3 deacetylase-independent versus deacetylase-dependent regulomes in the context 
of murine bone-marrow derived macrophages, employing a HDAC3 point mutation (Y298F) in the 
enzyme’s active site that disrupts its potent deacetylase activity. HDAC3 has been shown to be required 
for endotoxin (LPS)-stimulated gene activation in macrophages, but the underlying mechanism is 
unknown. We found that HDAC3 enzyme-independent function was indeed crucial for such activation, and 
that HDAC3 enzymatic activity was differentially engaged at distinct genomic regions, depending on its 
interacting partners. In the second aim of the study, the physiological relevance of HDAC3 enzyme activity 
in priming the innate immune system in response to endotoxic shock was examined, using both genetic 
and pharmacological blockage of HDAC3 enzymatic activity. Mice with macrophage-specific deletion 
HDAC3 produced significantly lower level of circulating inflammatory cytokines, enhancing their survival 
after being exposed to endotoxin. By contrast, animals harboring enzyme-dead HDAC3 hyper-activated 
the production of inflammatory cytokines that were detrimental in the endotoxin response. Taken 
together, these results place HDAC3 as the central integrator of external pathological stimulus to aid the 
immune system in mounting a well-balanced immunological response to ensure survival of the organism. 
This work advances our understanding of HDAC3 in transcriptional regulation as a dichotomous activator 
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DICHOTOMOUS ENGAGEMENT OF HDAC3 CATALYTIC ACTIVITY 
GOVERNS INFLAMMATORY RESPONSES  
Hoang C. B. Nguyen 
Mitchell A. Lazar 
Mammalian gene expression is activated by histone acetylation, which is 
reversed by histone deacetylases (HDACs) whose enzymatic functions are 
pharmaceutically targeted by HDAC inhibitors for cancer treatment and many other 
diseases. In addition to activating gene expression as predicted from their effects 
on the epigenome, HDAC inhibitors also silence transcription which is hard to 
understand based on current dogma. HDAC3 is particularly interesting because its 
enzyme activity requires interaction with Nuclear Receptor Corepressors 
(NCoR1/2). Remarkably, although global loss of HDAC3 is lethal owing to 
gastrulation defects, mice with mutations in the deacetylase-activating domains of 
both NCoR1 and NCoR2 are born in expected Mendelian ratios, despite lacking 
detectable HDAC3 enzymatic activity. These observations underlined the objective 
of this study, which is to elucidate the regulatory and physiological importance of 
HDAC3 non-enzymatic functions. The first aim of the study focuses on 
characterizing HDAC3 deacetylase-independent versus deacetylase-dependent 
regulomes in the context of murine bone-marrow derived macrophages, employing 
a HDAC3 point mutation (Y298F) in the enzyme’s active site that disrupts its potent 
deacetylase activity. HDAC3 has been shown to be required for endotoxin (LPS)-
vii 
stimulated gene activation in macrophages, but the underlying mechanism is 
unknown. We found that HDAC3 enzyme-independent function was indeed crucial 
for such activation, and that HDAC3 enzymatic activity was differentially engaged 
at distinct genomic regions, depending on its interacting partners. In the second 
aim of the study, the physiological relevance of HDAC3 enzyme activity in priming 
the innate immune system in response to endotoxic shock was examined, using 
both genetic and pharmacological blockage of HDAC3 enzymatic activity. Mice 
with macrophage-specific deletion HDAC3 produced significantly lower level of 
circulating inflammatory cytokines, enhancing their survival after being exposed to 
endotoxin. By contrast, animals harboring enzyme-dead HDAC3 hyper-activated 
the production of inflammatory cytokines that were detrimental in the endotoxin 
response. Taken together, these results place HDAC3 as the central integrator of 
external pathological stimulus to aid the immune system in mounting a well-
balanced immunological response to ensure survival of the organism. This work 
advances our understanding of HDAC3 in transcriptional regulation as a 
dichotomous activator and repressor, while highlighting the under-appreciated 
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GENERAL BACKGROUND AND SIGNIFICANCE 
 
1. HDAC3 belongs to the superfamily of histone deacetylases 
Histone deacetylases are a group of enzymes that catalytically erase acetyl 
groups from lysine residues on histone tails. As a result of this catalysis, DNA 
wraps around histone more tightly, denying access to transcriptional machinery 
with subsequent repression of genes. HDAC1 was the first HDAC to be discovered 
by Schreiber (Taunton et al., 1996), which bears structural resemblance to the rpd3 
transcription factor in yeast (Kadosh and Struhl, 1998, Rundlett et al., 1996; 
Taunton et al., 1996; Yang and Seto, 2008). Since then, ten additional members 
of this highly conserved family were characterized, further divided into 4 classes. 
Class I HDACs consists of HDAC1, 2, 3, and 8, all of which are closely related to 
HDAC1. The second class of HDACs are sub-divided into Class IIa (HDAC4, 5, 7, 
9), class IIb (HDAC6, 10). Sirtuins are class III HDACs that require NAD+ for 
enzymatic deacetylation of histones (Chalkiadaki and Guarente, 2012; Chang and 
Guarente, 2014; Schwer and Verdin, 2008). HDAC11 is the only member of Class 
IV, which also requires Zinc metal for enzymatic functions similarly to Class I and 
II (Yang and Seto, 2008). 
   
2. The identification and importance of co-repressor complexes in 
regulating HDAC3 enzymatic activity 
2 
 
Work from the Lazar lab and others have reproducibly showed the predominant 
role of HDAC3 with the nuclear receptor corepressors. Li and Guenther in 2000 
identified independently for the first time that HDAC3 was a stoichiometric 
component of complexes containing Nuclear Receptor Corepressor (NCOR or 
NCoR1, Li et al., 2000) and Silencing Mediator of Retinoid and Thyroid Receptors 
(SMRT or NCoR2, Guenther et al., 2000). Other bona-fide components of the 
complex include TBL1 (Guenther et al., 2000), TBL1R (Yoon et al., 2003) and 
GPS2 (Zhang et al., 2002), which have been reliably reproduced in many high-
throughput proteomic studies in our lab in multiple tissues. Though some studies 
have shown that other Class I HDACs could interact with NCoR1/NCoR2 in vitro, 
only HDAC3 had been found in endogenous complex with NCoR1/NCoR2 (Heinzel 
et al., 1997; Kao et al., 2000; Nagy et al., 1997). More importantly, this association 
with the co-repressor complexes through the deacetylase-activating domain (DAD) 
was shown to be required for enzymatic activation of HDAC3 (Guenther et al., 
2001). Mice harboring Y470A mutation in SMRT (S-DADm) and the Y478A 
mutation in NCOR1 (N-DADm), also known as NSDAD mice, completely 
abrogated HDAC3 catalytic activity in vivo (You et al., 2013). In 2012, Watson and 
colleagues developed the first crystal structure for HDAC3 in association with 
NCoR2, which also revealed the unexpected presence of inositol tetraphosphate 




3. Evidence of HDAC3 enzyme-independent functions 
HDAC3 intrinsic enzymatic functions were reported to be dispensable for 
survival (Alenghat et al., 2008; You et al., 2013) despite the fact that loss of HDAC3 
is incompatible with life (Bhaskara et al., 2010; Lewandowski et al., 2014; 
Montgomery et al., 2008). Moreover, pharmaceutical inhibition of catalytic activity 
by HDAC inhibitor does not always increase transcription or correlate with changes 
in acetylation level (Mullican et al., 2011, Lopez-Atalaya et al., 2013). In fact, 
enzyme-dead mutant HDAC3 can rescue not only the phenotypic hepatic steatosis 
conferred by loss of HDAC3 (Sun et al., 2013) but also defects in early cardiac 
developments (Poleshko et al., 2017). Despite these interesting observations, it 
remains unknown the scope of impact of HDAC3 deacetylase-independent 
function and the mechanisms underlying the physiological basis of its existence. 
Further biological insights into this underappreciated function of HDAC3 bears 
critical implications for the pharmaceutical development of deacetylase-targeting 
drugs. 
4. HDAC3 is crucial to all aspects of life 
Despite being one of the 11 mammalian HDACs, HDAC3 is not functionally 
redundant as loss of HDAC3 at the germline stage led to early lethality during 
embryogenesis (Bhaskara et al., 2008; Lewandowski et al., 2015; Montgomery et 
al., 2008), 
Tissue-specific knock-out of HDAC3 also resulted in devastating defects, 
exemplified in the brain, heart, lungs, liver, reproductive system, brown adipose 
tissue, hematopoietic lineages, as well as the microbiota in a recent study. 
4 
Loss of HDAC3 in the central nervous system that is underdeveloped led to 
perinatal lethality by 16 hours of birth, resulting from widespread abnormalities in 
organization and structure of the cortex, cerebellar cortex, and neocortex. (Morris 
and Monteggia, 2013; Norwood et al., 2014) 
Genetic deletion of HDAC3 in cardiac progenitor cells of the first and second 
heart is completely lethal by embryonic day 11.5 (Lewandowski et al., 2015). 
Moreover, defects in differentiation of ventricular and septal cardiomyocytes were 
also reported (Singh et al., 2011). 
Ablation of HDAC3 in the lung mesenchyme was lethal at birth with animals 
dying from the inability to breathe (Wang et al., 2016). Moreover, reduction in 
Hdac3 in the underlying mesoderm could also lead to severely underdeveloped 
lungs. 
Hepatic steatosis, or fat in the liver, is the most pronounced consequent of 
genetic HDAC3 knock-out in the liver, both early (Knutson et al, 2008) and late 
(Feng et al., 2011; Sun et al., 2012) in life. Interestingly, these mice are not insulin 
resistant as in the case of diet-induced fatty livers.  
In 2019, Kim and colleagues reported that loss of HDAC3 results in 
nonreceptive endometrium and female infertility, which was the first study of its 
kind to demonstrate the role of HDAC3 in the reproductive system. HDAC3 was 
directly implicated in endometrial receptivity and decidualization, and was found to 
be reduced in infertile women with endometriosis.  
Recent work from our lab in the interscapular brown adipose tissue (BAT) 
demonstrates the crucial role of HDAC3 in preparing mice for cold challenge. 
5 
Animal lacking HDAC3 in BAT failed to maintain body temperature when exposed 
to acute hypothermia (Emmett et al., 2017). 
HDAC3 was also shown to play important role in development of hematopoietic 
lineages, with loss of HDAC3 resulted in anemia, afunctional thymus, dysfunctional 
B- and T-cell development (Bhaskara et al., 2010; Summers et al., 2013, as well 
as defects in macrophage polarizations. (Chen et al., 2011, Mulican et al., 2011) 
Lastly, HDAC3 was demonstrated to be required for the intestinal microbiota to 
shape the diurnal rhythms in host metabolism (Kuang et al., 2019). Loss of HDAC3 
in the intestine led to worsened both high fat diet-induced and jet-lagged induced 




MATERIALS AND METHODS 
 
Statistics and Reproducibility. All data were presented with individual 
biological replicates shown when appropriate. RStudio (v1.0.153) with R-
packages: edgeR(v3.26.8), ggplot2 (v3.3.0), latticeExtra(v0.6-29), pheatmap 
(v1.0.12) softwares and Graphpad Prism (v8.0) were used for graphing and 
statistical analysis. Genome-browser tracks were visualized with IGV 2.3.92 
(Robinson et al., 2011). All statistical tests are fully described in the figure 
legends. In general, p values were calculated using two-tailed Student’s t-test 
for pairwise comparisons and one-way ANOVA for multiple comparisons. All 
statistical tests were adjusted with Holm-Sidak method for multiple testing, with 
a 95% confidence interval. Hypergeometric testing was either reported by 
HOMER(v4.11) (Heinz et al., 2010), Enrichr(v2.1) (Chen et al., 2013;  Kuleshov 
et al., 2016), or was performed with R-function phyper(). Statistics reported by 
Enrichr (q-values) were adjusted by Benjamini-Hochberg (BH) method. 
Correlations with associated p values from two-sided t-tests were calculated by 
R function cor().  
Animal studies. MHD3KO mice were generated as previously described 
(Mullican et al., 2011). NSDAD mice were generated as previously described 
(You et al., 2013). Mice were housed in a temperature-controlled specific-
pathogen-free facility under 12-hour light/dark cycles. Adult male mice of 8 
7 
weeks old were used in all experiments. Age-matched WT C57Bl6 mice were 
purchased from Jackson lab.  No calculation was performed to pre-determine the 
sample size. Animal care and use procedures followed the guidelines of the 
Institutional Animal Care and Use Committee of the University of Pennsylvania 
in accordance with the guidelines of the National Institutes of Health. All 
experimental procedures were performed according to institutional pain class C 
protocol. 
In vivo endotoxic shock study. All procedures were performed according to 
institutional pain class C protocol. Mice were intraperitoneally injected with 
10mg/kg of purified LPS (Sigma E. Coli O111:B4) and closely observed 
continuously every 4 hours for the first 48 hours post endotoxin exposure, for a 
total of 120 hours. SAHA administration (Peprotech; 25-400mg/kg every 24 
hours, or 10% DMSO in PBS vehicle control) was started 1 day before LPS 
injection and continued daily until experimental end point. Mice of different 
genetic backgrounds or treatments were randomized, and identities were 
blinded from the experimenter until final census. All surviving animals were 
humanely euthanized after 120 hours post injection. Experiments were 
performed independently twice. 
ELISA. Circulating cytokine levels from mouse serum harvested 6 hours after 
administration of endotoxin were measured with Mouse Quantikine ELISA kits 
(TNFα, MTA00B; IL6, M6000B) according to the manufacturer’s instructions.  
Chemiluminescence was measured at wavelength 450nm by Synergy HT plate 
8 
reader (Biotek) and cytokine concentrations were quantitated using a four-
parameter fit curve. 
In vivo transcription profiling. WT C57Bl6, MHD3KO, NSDAD mice and their 
control littermates of 8-week-old were intraperitoneally injected with either 
phosphate-buffered saline (PBS, Sigma) or 10 mg/kg of purified LPS (Sigma E. 
Coli O111:B4) at 4PM. Without thioglycolate stimulation, peritoneal macrophages 
were harvested 6h after LPS or PBS injection at 10PM and passed through pre-
separation filters (Miltenyi Biotec, 130-041-407) to obtain a single-cell suspension. 
Peritoneal macrophages were then isolated by MACS (Magnetic-Activated Cell 
Sorting) as previously described (Li et al., 2013), following the manufacturer 
instructions (Miltenyi Biotec, 130-110-434) and using MiniMACS columns (Miltenyi 
Biotec, 130-042-201). RNA was isolated from purified cells using TRIzol 
(Invitrogen) with the RNeasy micro kit (Qiagen). 
Cell culture. Bone marrow-derived macrophages (BMDM) were harvested and 
cultured as previously described (Mullican et al., 2011). Briefly, DMEM 
supplemented with 30% L929 (Sigma, 8501) conditioned medium, 10% fetal 
bovine serum (Tissue Culture Biologics), 100 U/mL penicillin, and 100 µg/mL 
streptomycin (Invitrogen) was used to culture and differentiate cells for 7 days 
in petri plates, with fresh media replaced on the 4th day and replating on the 6th 
day post-harvest. Cells were then treated with PBS (vehicle), 10 ng/mL IL-4 
(Peprotech) for 24 hours, or 5 ng/mL LPS (Sigma) for 4 hours. For HDAC 
inhibitor studies, a 4-hour pre-treatment of either vehicle control (10% DMSO) 
or 25-400nM SAHA (Peprotech) prior to the addition of vehicle or LPS was 
9 
performed. All cell cultures were maintained at 37oC in 5% CO2 incubators. No 
cell line authentication or mycoplasma contamination testing was performed. 
Retroviral expression of exogenous HDAC3 mutant. Sequencing-confirmed 
wild-type HDAC3 (WT-rescue) and Y298F cDNAs were cloned into a MSCV 
retroviral construct. Retroviruses were produced in HEK-293FT (Invitrogen 
R70007) cells by co-transfection of MSCV containing either no insert (empty 
vector), Y298F, or WT-rescue and pCL-Eco vectors with FuGENE 6 (Promega), 
and supernatants were harvested 72 hours post-transfection. Supernatants from 
three 15cm2 tissue culture dishes (1.0x107 cells/dish) were passed through a 
0.20μm filter (Corning) prior to viral concentration with PEG-it Virus Precipitation 
Solution (System Biosciences) at 4°C to a final stock volume of 600μL. 
Concentrated retrovirus was added to 1.0x106 differentiating macrophages on 
day 4 (of the 7-day period) in DMEM containing 2 μg ml−1 polybrene. Fresh media 
containing 1 μg ml−1 puromycin was added 48 hours later for selection of 
successful viral transduction, up to the next 4 days. We empirically determined 
that using 300ul (titration was done at 50, 100, 200, 300, 400, 500 μl) of the 
concentrated viral stock allows re-expression of exogeneous HDAC3 and Y298F 
mutant to a level comparable to endogenous HDAC3. Importantly, to control for 
viral transduction, control and MHD3KO macrophages were also transduced 
with retroviruses carrying the empty vector. 
DsiRNA-mediated gene silencing. After the 7-day period differentiation of 
macrophages as described above, 5.0x106 cells were plated overnight in 10-cm 
tissue culture dishes. The media was replaced with 10 ml of serum-free, antibiotic-
10 
free DMEM for maximum transfection efficiency. For each target gene, 3 different 
siRNAs (IDT DsiRNA) were used as independent biological replicates. 
Transfection was done with Lipofectamine RNAiMax and siRNAs, or transfection 
control per manufacturer’s protocol, with total RNAi concentration held constant at 
50nM. 48 hours post-transfection, transfected BMDM were harvested. Knock-
down of specific genes was confirmed by qRT-PCR and Western Blot prior to 
downstream experiments. Gene-specific siRNA sequences can be found in 
Supplementary Table 1.  
Dual Luciferase Assays. For unbiased selection of enhancer elements for 
reporter genes, first, consensus sequences for 200-bp DNA-sequences of 
enhancer elements upstream of DA-independent genes (171) and DA-dependent 
genes (142) were obtained using Clustal Omega multiple-alignment tool. The 
200bp enhancer element 14kb upstream of Clec2d was selected for ATF2 reporter 
gene assay since it mapped best to the consensus sequence of 171 enhancer 
elements (multi-mapping score 151/200 bp, allowing gaps) for DA-independent 
genes. Similarly, the 200bp enhancer element 16kb upstream of Gas6 was 
computationally selected for ATF3 reporter gene assay (multi-mapping score 
177/200bp, allowing gaps) since it mapped best to the consensus sequence of 142 
enhancer elements for DA-dependent genes. Mutant reporter gene was generated 
by mutating the intrinsic ATF2 motif to ATF3 motif for the ATF2 reporter, and vice 
versa for the ATF3 reporter. Unique flanking 5′ and 3′ extensions allowing for 
enzyme restriction digest were added as PCR anchor points. DNA cassettes were 
purchased as Ultramers from IDT, PCR amplified, and subcloned into the pGL4.24 
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vector (Promega) with a minimal promoter using KpnI and XhoI restriction enzyme 
(NEB). Full-length sequences for each multimerized motif are available in 
Supplementary Table 1. For luciferase assays, BMDM were seeded at 1.0x104 cell 
per well in a 96-well plate, co-transfected with 10 ng of luciferase reporter 
construct, 4 ng of CMV-Renilla plasmid, using 0.3 μl of Lipofectamine 2000 per 
well, in a reverse transfection protocol. Cells were lysed in passive lysis buffer 
(Promega Dual Luciferase Kit) 48 hours post-transfection. Luminescence was read 
by Synergy HT plate reader (Biotek). Four biological replicates were used in each 
condition. Firefly luciferase signal was normalized to renilla luciferase signal to 
account for transfection efficiency. 
 
Gene expression measurement. RNA was isolated from cells using TRIzol 
(Invitrogen) and purified with the RNeasy minikit (Qiagen). qRT-PCR was 
performed using 500ng-1μg of RNA (Applied Biosystems) following the 
manufacturer’s instructions. qRT-PCR was performed on cultured macrophages 
using primers listed in Supplementary Table 1, with SYBR Green Master Mix 
(Applied Biosystems) on the QuantStudio 6 Flex Real-Time PCR system (Applied 
Biosytems). qPCR analysis was performed using the standard curve method, and 
all genes were normalized to the housekeeping gene 36b4. All qPCR experiments 
were done with at least 3 biological replicates per condition. For RNA-seq, RNA 
integrity was examined using Agilent RNA 6000 nano kit. 1μg of RNA samples 
with RNA integrity number >7 were used for RNA cleanup and library preparation 
with Illumina Truseq Stranded Total RNA Library Prep kit according to 
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manufacturer’s instructions. All barcoded libraries were quantified by KAPA Library 
Quantification Kit (Roche), and equimolarly pooled for subsequent sequencing. All 
RNA-seq experiments were done with at least 3 biological replicates per condition. 
For each biological replicate, macrophages were pooled from at least 3-4 different 
mice.  
RNA-seq data processing. All RNA-seq libraries were sequenced on Illumina 
HiSeq2000, Hiseq4000, Nextseq500, or Novaseq6000 platform. Sequencing 
reads were aligned to the UCSC mm10 genome using STAR(v2.6.0a) (Dobin et 
al., 2012) with the following parameters: --outFilterMultimapNmax 1 --outSAMtype 
BAM SortedByCoordinate --readFilesCommand zcat --outSAMstrandField 
intronMotif. Read counts were then obtained from mapped bam files with 
featureCounts (v1.5.3) (Liao et al., 2013) with the following parameters: -t exon -g 
gene_id -s 1 -T 20. To filter out lowly expressed genes, raw read counts were 
transformed into Transcripts-per-kilobase-million (TPM) and only genes with TPM 
> 0.1 in at least two of the biological replicates were kept in the count matrix for 
further downstream differential expression analyses. edgeR estimateDisp() and 
calcNormFactor() functions were used to estimate intrinsic dispersion and 
calculation normalization factors to account for variations in sequencing depth, 
respectively. Normalized read counts were fit to a negative binomial generalized 
log-linear model with glmFit(). To account for changes in two variables 
simultaneously, for example, LPS and HDAC3, multi-variable design matrices 
were used. Differentially expressed (DE) genes (cut-off defined as |log2FC| > 1, 
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two-sided BH-adjusted FDR < 0.05) were identified using edgeR likelihood ratio 
test glmLRT().   
To identify DA-independent transcriptome, first LPS-stimulated differentially 
expressed genes (|log2FC| > 1, FDR < 0.05) were identified from a) contrast 
between Y298F vs. MHD3KO: [(Y298F LPS – Y298F veh) –(MHD3KO LPS- 
MHD3KO veh)], b) contrast between control vs. MHD3KO: [(control LPS – control 
veh) –(MHD3KO LPS- MHD3kO veh)], c) contrast between WT-rescue vs. 
MHD3KO: [(WT-rescue LPS – WT-rescue veh) –(MHD3KO LPS- MHD3KO veh)]. 
DA-independent genes were classified as those that fit the null hypothesis of 
equality (i.e. no difference, FDR > 0.05) for the Y298F-rescue contrasts of [(Y298F 
vs. MHD3KO) – (control vs. MHD3KO)] and [(Y298F vs. MHD3KO) – (WT-rescue 
vs. MHD3KO)]. Similarly, the DA-dependent transcriptome fit the null hypothesis 
of equality for the contrasts of [(Y298F vs. control) – (MHD3KO vs. control)] and 
[(Y298F vs. WT-res) – (MHD3KO vs. WT-res)]. As such, for DA-independent 
genes, the Y298F transcriptome was statistically modelled to be overlapping with 
both control and WT-rescue, while maximally distant to MHD3KO. Meanwhile, for 
DA-dependent genes, Y298F transcriptome was statistically modelled to be 
overlapping with MHD3KO, while maximally distant to both control and WT-rescue. 
Cumulative distribution function (CDF) plots for DA-independent and DA-
dependent transcriptomes were made with R package latticeExtra function 
ecdfplot(). Heatmaps were generated with R package pheatmap using z-
transformed TPM or log2(FC) values across all biological replicates and treatment 
conditions. Gene ontology analyses of DA-independent, LPS-upregulated and DA-
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dependent, LPS-down-regulated genes were performed by Enrichr  reporting 
terms with the most significant reported q-values (<0.05). Gene set enrichment 
analyses were performed with GSEA software (Mootha et al., 2003; Subramanian 
et al., 2005) using genesets provided directly from 
http://software.broadinstitute.org/gsea/. 
GRO-seq and data processing. GRO-seq was performed as previously 
described (Wang et al., 2011; Kainoken et al., 2013) with the following 
modifications: BMDM were harvested from control and MHD3KO using 3 
independent biological replicates per condition. For each biological replicate, 
BMDM from 10 different mice were pooled together before being treated with either 
PBS control or 5ng /ml of LPS for 4 hours prior to the harvest. Cells were washed 
twice with ice cold PBS, then put in cold swelling buffer (10mM Tris at pH 7.5, 2mM 
MgCl2, 3mM CaCl2) for 5 min on ice. Cells were scraped off and centrifuged at 
400g for 10 min. The nuclei were then extracted using lysis buffer (swelling buffer 
with 10% glycerol and 1% Igepal). After two washes with lysis buffer, nuclei were 
resuspended in freezing buffer (50 mM Tris pH 8.3, 40% glycerol, 5 mM MgCl2, 
0.1 mM EDTA). 1.0 x 107 nuclei were used for each library. The nuclear run-on 
reaction was incubated in run-on buffer (10 mM Tris pH 8.0, 5 mM MgCl2, 1 mM 
DTT, 300 mM KCl, 200 U/ml Superase-In, 1% Sarkosyl, 500 mM ATP, GTP and 
Br-UTP, 2 mM CTP) for 7 min at 30°C. Nascent transcripts were enriched with anti-
BrUTP antibodies. After 10 min of RNA hydrolysis and reverse transcription, all 
products were used for GRO-seq library preparations in parallel to reduce batch 
effect.  
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GRO-seq libraries were barcoded and sequenced on the Illumina 
HiSeq4000 platform. Bidirectional eRNA identification was performed as 
previously described (Fang et al., 2014, Emmett et al, 2017). HDAC3-colocalized 
eRNAs were identified by overlapping all HDAC3 genomic sites with all 
bidirectional eRNA sites using bedtools (Quinlan and Hall, 2010) intersectBed. 
Bidirectional eRNA signal density at specific HDAC3 peak regions were obtained 
with annotatepeaks.pl with a 2kb window from HDAC3 peak center, using the 
option -size 2000 -hist  with a 25bp bin size.  Average density profiles were 
generated with mean signal in normalized reads-per-million (RPM) and error bands 
for biological replicates. Density profile statistics were calculated with Wilcoxon 
rank sum test by R-function wilcox.test(), for two independent samples with no 
assumption of normal distribution and a null hypothesis of equal medians (x-y= µ 
= 0) 
Western blot. Cellular lysates were prepared by lysing cells (0.5-1.0x107) in ice-
cold RIPA buffer containing protease and phosphatase inhibitors (Roche). For 
H3K27Ac immunoblot, HDAC3 inhibitor cocktail (sodium butyrate, nicotinamide, 
and trichostatin A) was also added to lysis buffer. Cellular debris was removed by 
centrifugation (15,000 rpm) for 20 min at 4°C. Protein concentration was measured 
with Pierce™ BCA Protein Assay Kit (Fisher 23225) and all samples were 
normalized to the same input protein concentration. Samples were denatured in 
loading buffer, separated using SDS–PAGE, transferred to a PVDF membrane 
(Pierce), blocked with Odyssey® TBS Blocking Buffer (LICOR 927-50100), and 
probed using target-specific primary antibodies (listed in Supplementary Table 1) 
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at 1:1000 dilution. Bound primary antibodies were detected by species-specific 
LICOR fluorescent IRDye® secondary antibodies (IRDye® 800CW Goat anti-
Mouse 925-32210 lot# C70712-11 1:20,000 dilution; IRDye® 680RD Donkey anti-
Rabbit 926-68073 lot# C90129-15 1:20,000 dilution). Immunoblots were imaged 
with the Odyssey® Sa Infrared Imaging System according to the manufacturer’s 
instructions. Dual-channel color (red/green) blots were converted to grayscale for 
color-blind friendly visualization purposes. Blots were cut appropriately by 
molecular weight whenever cross-species antibodies were used to reduce 
background (resulting from using murine-derived antibodies in murine-derived 
tissues).  
Immunoprecipitation. Fully differentiated BMDM or peritoneal macrophages 
were lysed with ChIP buffer (50nM Tris-HCl pH 7.5, 500mM NaCl, 1mM EDTA, 1% 
Triton-X 100, 0.1% sodium deoxycholate, 0.1% SDS, supplemented with 
cOmplete Protease Inhibitor, Roche, for H3K27Ac, HDAC3 inhibitor cocktail with 
sodium butyrate, nicotinamide, and trichostatin A was also added), incubated on 
ice for 30 min, and centrifuged at max speed for 30 min to collect cell debris at 
4°C. 5% of the cleared lysates were saved as input. Lysates were subjected to 
BCA protein quantification to normalize the amount of input material subjected to 
immunoprecipitation. Lysates were then incubated with antibody overnight at 4oC, 
followed by immunoprecipitation with Protein A Sepharose CL-4B  beads (30ul wet 
beads/ IP) for 6 hours at 4°C. Beads were subsequently subjected to 1x 5-min 
wash with ChIP-buffer, 1x 5-min wash with ChIP-buffer with additional 500nM 
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NaCl, 1x 5-min wash with Wash buffer (10nM Tris-HCl pH 8.0, 250mM LiCl, 0.5% 
NP-40, 10% sodium deoxycholate, 1mM EDTA). 
HDAC activity assay. HDAC3 deacetylase activity was measured with the HDAC 
Assay Kit (Active Motif 56200) according to manufacturer’s instructions on 
immunoprecipitated HDAC3 (as described above) from control, MHD3KO, Y298F, 
or WT-rescue BMDM with 1mg of starting material using anti-HDAC3 antibody 
(Abcam 7030). Substrate solution containing short peptides with acetylated lysine 
residues were added directly to the HDAC3-antibody-Protein A bead slurry 
complex. After incubation with developing solution, fluorescent signals from 
standards and samples were detected by a plate reader system (Biotek Synergy 
HT), and deacetylase activity was determined by the standard curve method. 
ChIP-seq and data processing. All reported ChIP-seq experiments were done in 
three independent biological replicates, except for HDAC3 ChIP-seq in ATF2, 
ATF3, or p65 depleted cells where there were two independent biological 
replicates per condition. For each biological replicate, BMDM were pooled from at 
least five different mice for sufficient input material. 1.0x107 BMDM were 
crosslinked on a petri plate with 1% formaldehyde for 15 minutes at room 
temperature, then quenched with 2.5M glycine for 5 minutes.  Cross-linked cells 
were then scraped off the plates in PBS, collected by centrifugation 1000g x 
5minutes, and lysed in 1mL ChIP buffer (described above) and placed on ice for 
10 minutes. Chromatin fragmentation was performed with microtip probe sonicator 
(Fischer Scientific, FB705 Sonic Dismembrator) at 4oC with the following settings: 
3x 10% amplitude for 10 seconds, followed by 3x 15% amplitude for 15 seconds, 
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with a 30-second pause in between each sonication. Chromatin was then cleared 
with centrifugation at maximum speed for 30 minutes at 4oC, 5% saved for input, 
and incubated with antibodies (listed in Supplementary Table 1) overnight at 4oC. 
Immunoprecipitation of ChIP DNA is similar to IP procedure described above, 
except for reversal of cross-linking overnight at 65oC with elution buffer (50 mM 
Tris-HCl pH 8.0, 10 mM EDTA, 1% SDS), before being treated with 0.33 mg/ml 
RNase A (Fisher EN0531) and 0.5 mg/ml Proteinase K (Fisher 2546) at 37oC for 
1 hour. DNA was isolated with phenol/chloroform followed by overnight -20oC 
ethanol precipitation. ChIP DNA was prepared for sequencing according to the 
amplification protocol provided by Illumina.  
All ChIP-seq libraries were barcoded and sequenced on NextSeq500 or 
HiSeq4000. Sequencing reads of were aligned to the UCSC mm10 genome using 
Bowtie2 (v2.2.6) (Langmead and Salzberg, 2012) with the following parameters -
p 20 -N 1. Mapped reads were processed into tag counts, filtered for PCR 
duplicates, corrected for read-depth bias, and fragment lengths for each biological 
replicate with HOMER51 functions makeTagDirectory -tbp 1 -fragLength 150 -
totalReads 2e7.  For peak calling, findPeaks function was used with parameter -
size 200 to resize all peaks to a uniform size of 200bp. As background, input 
samples were used, except for HDAC3 where MHD3KO was used. Peaks were 
called independently for each replicate. Only peaks that are present in at least two 
biological replicates are considered “true" peaks. Peaks are defined as foldchange 
IP/input(KO) > 4, FDR < 0.0001. Genome browser tracks were generated with 
HOMER function makeUCSCfile -bigWig -fsize 1e20 and corrected for variations 
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in read-depth with -norm 2e7. For identification of HDAC3 peaks near DA-
independent and DA-dependent genes, bedtools window -l 1e5 was used on 
genomic location of respective transcription start sites (obtained from 
genome.ucsc.edu) and HDAC3 peaks. For each gene, only the closet peak was 
counted. For peaks that happened to be close to both an DA-independent gene 
and an DA-dependent gene, whichever one closer to the peak was assigned. 
ChIP-seq signal density at specific peak regions were obtained with 
annotatepeaks.pl with a 2kb window from peak center, using the option -size 2000 
-hist (for histograms) or -ghist (for heatmaps) with 25bp bin size.  Average density 
profiles were generated with mean signal in normalized reads-per-million (RPM) 
and error bands for biological replicates. Density profile statistics were calculated 
with Wilcoxon rank sum test by R-function wilcox.test(), for two independent 
samples with no assumption of normal distribution and a null hypothesis of equal 
medians (x-y= µ = 0). De novo motif analyses were performed with HOMER 
function findMotifsGenome.pl. For identification of motifs specific to DA-
independent and DA-dependent sites, a machine learning-based transcription 
factor binding analysis (TBA) (Fonseca et al., 2019( was applied to HDAC3-bound 
genomic regions near DA-independent genes and DA-dependent genes. TBA 
(v1.0) was operated under recommended parameters 
(https://github.com/jenhantao/tba) with multi-threading and option -p to test for 
significance with a likelihood ratio test. For differential motif enrichment, DA-
independent and DA-dependent genomic sites were cross-compared against each 
other as input and background, and vice versa. Enrichment score heatmap was 
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generated using -log10(hypergeomtric p-value) for enrichment and 
log10(hypergeometric p-value) for depletion. ChIP-seq quality controls, including 
the number of mapped reads, peak counts, and FriP score are provided in 















IDT Ultramers ATF2/Clec2d  reporter ATF3/ Gas6 reporter
Wild-type sequence TGGTGCACCAGGGAGCATTTGAGCTCAGAATCACTCCG GCAGCAGGGAGAAGTCCTCACGTCGGGCGTGGTG
Clec2d : Endogenous ATF2 motif highlighted in red ATTATTTCCTGAGCTCAGAGTGAGCTCATATGCTGTTTCTTGACTCAGGCATGCAGAAGGAAACCTCAGTGTCC





Clec2d : Mutated ATF2 motif highlighted in blue TGGTGCACCAGGGAGCATTTGACTCAGAATCACTCCGA GCAGCAGGGAGAAGTCCTCACGTCGGGCGTGGTG





Anchor primers for ultramers Forward (5'-3') Reverse(5'-3')
DA-independent enhancer/ATF2 motif atatGGTACCTGGTGC gcgcCTCGAGAAGAGG
DA-dependent enhancer/ATF3 motif atatGGTACCGCAGCAGGG atatCTCGAGTGGTCCCT





Antibodies(for IP: 5ul/1ml lysate, for WB: 1:1000 dilution) Rabbit Mouse
HDAC3 Abcam, monoclonal 7030 (lot# GR121157-6)
p65 Cell signaling, monoclonal D14E12 (lot# 13)
Vinculin Sigma, monoclonal V9131(lot#128M4852V)
ATF2 Cell Signaling, monoclonal D4L2X (lot# 1)
ATF3 Cell Signaling, monoclonal D2Y5W  #33593(lot# 1)
H3K27Ac Abcam 4729 (lot# GR251958-1)
Histone H3 Abcam 24834(lot# GR236539)
NCoR1 Cell Signaling E4S4N(lot# 1)
NCoR2 Milipore AntiSMRTe 06-891 (lot# 2982400)
Supplementary Table 1: List of siRNAs, Ultramers, primers, and antibodies
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Supplementary Table 2: ChIP-seq quality control
ChIP-seq Average mapped reads % Total reads Average number of peaks Average FRiP score
HDAC3 veh 36534251 90 6432 0.47
HDAC3 LPS 31350827 91 10996 1.08
ATF2 veh 26401863 89 14180 2.84
ATF2 LPS 31255484 92 19594 3.98
ATF3 veh 25270100 90 28134 4.39
ATF3 LPS 21025349 90 57041 15.5
NCOR1 veh 30443764 94 15248 5.6
NCOR1 LPS 36793384 95 26233 12.45
NCOR2 veh 29783528 90 49730 13.1
NCOR2 LPS 28238407 92 60085 15.4
p65 veh 30024703 91 1416 0.41
p65 LPS 25200141 93 13289 2.87
H3K7Ac veh 30385408 90 50247 66.33





DICHOTOMOUS ENGAGEMENT OF HDAC3 CATALYTIC ACTIVITY 




Histone deacetylase 3 (HDAC3) is unique among the HDAC superfamily of 
chromatin modifiers that silence transcription through enzymatic modification of 
histones because interaction with nuclear receptor corepressors (NCoR1/2) is 
required for engagement of its catalytic activity. However, loss of HDAC3 also 
represses transcription. Here we report that, during lipopolysaccharide (LPS) 
activation of macrophages, recruitment of HDAC3 to ATF2-bound sites without 
NCoR1/2 non-canonically activates inflammatory gene expression. By contrast, 
HDAC3 deacetylase activity is selectively engaged at ATF3-bound sites that 
suppress toll-like receptor (TLR) signaling. Deletion of HDAC3 in macrophages 
safeguards mice from lethal exposure to LPS, but this protection is not conferred 
by genetic or pharmacological abolition of HDAC3 catalytic activity. Thus, HDAC3 
is a dichotomous transcriptional activator and repressor whose non-canonical 




Histone deacetylases (HDACs) are integral enzymes that participate in 
myriads of cellular activities such as epigenomic maintenance, chromatin 
remodeling, and transcriptional regulation through post-translational modifications 
of acetyl groups (Choudhary et al., 2009). Of the 11 HDAC isoforms encoded by 
the mammalian genome, HDAC3 garnered special interest due to the unique 
characterization of the required co-binding of nuclear receptor corepressor 
complexes, NCoR1 and NCoR2, for activation of the deacetylase domain and 
subsequent gene repression (Guenther et al., 2001; Watson et al., 2012; You et 
al., 2013). Understandably, HDAC enzymatic activity quickly became a major 
pharmaceutical target. Several HDAC inhibitors were approved for treatment of 
cancer (Gryder et al., 2012), with many ongoing clinical trials examining their 
benefits in cardiovascular and neurodegenerative diseases, as well as potential 
anti-inflammatory properties (Roger et al., 2011; De Souza et al., 2015; Kazantsev 
et al., 2008).  Unsurprisingly, the strategy of non-specific HDAC inhibition is fraught 
with potential toxicities, including serum electrolyte imbalances, neurocognitive 
impairment, liver damage, and cardiovascular abnormalities (Roger et al., 2011; 
De Souza et al., 2015; Kazantsev et al., 2008; Leus et al., 2016). In animal models, 
inhibition of deacetylase activity has reportedly been associated with poorly 
understood, yet commonly seen, gene repression (Roger et al., 2011; Leus et al., 
2016; Yoon et al., 2016). Though classically associated with transcriptional 
repression, growing body of evidence suggested an alternative HDAC3 regulatory 
fate where its genomic occupancy is required for transcriptional activation (Sun et 
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al., 2013; Greet et al., 2015; Lewandowski et al.; 2015, Emmett et al., 2017).  In 
contrast to the lethality conferred by global loss of HDAC3, genetic inactivation of 
HDAC3 enzymatic activity through disruption of the deacetylase-activating domain 
(DAD) of NCoR1 and NCoR2 is compatible with life with no overt physiological 
abnormalities (You et al., 2013). The potent deacetylase activity of HDAC3 can 
also be abolished by point mutations in the active site of the enzyme at tyrosine 
298 (Y298F), by mutation of two catalytically important histidine residues (H134A–
H135A; known as the HAHA mutant) or by mutation of a lysine at the interface of 
HDAC3 with IP4 and DAD (K25A) (Sun et al., 2013). The Y298F mutant, in 
particular, has previously been shown to partially rescue hepatic steatosis caused 
by loss of HDAC3 (Sun et al., 2013). Such evidence highlights the importance of 
investigating HDAC3 non-enzymatic functions and their physiological relevance, 
which remains mechanistically poorly characterized and bears critical implications 
for the development of deacetylase-targeting drugs. Delineating the pathways that 
uniquely require HDAC3, and determining whether its enzymatic activity is 
necessary, will inform more specific HDAC3-targeted therapies that, for example, 
act at its catalytic core or at the level of its protein interactions. 
Macrophages are key players of innate immunity. They are the first 
responders to pathogens and launch protective pro-inflammatory signals to 
combat such invasion while timely promoting an anti-inflammatory phenotype to 
limit damage and promote tissue repair. This intricate immunological balance is 
crucial to life, and many diseases such as cancer, diabetes, multiple sclerosis, 
arthritis, and sepsis arise from pathological imbalances of such inflammatory 
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responses (Chen et al., 2012; Mullican et al., 2011; Mills et al., 2018; Bambouska 
et al., 2018; Barish et al., 2010). Unfortunately, our understanding of the key 
regulators of this process remains limited due to the sheer complexity of the 
resulting extensive transcriptional and metabolic rewiring (Mills et al., 2018; 
Bambouska et al., 2018). Recent studies reported that loss of HDAC3 impaired 
inflammatory response activation due to paradoxical down-regulation of pro-
inflammatory genes in macrophages (Chen et al., 2012; Yan et al., 2012), while 
HDAC inhibitors impair key immunologic axes driven by NF-kB, Irg1, and Tlr4 
(Wang et al., 2007;  Zhu et al., 2010; Ziesche et al., 2012; Chen et al., 2018). 
Interestingly, work from our lab and others implicated bifunctional modes of 
HDAC3 regulation in macrophage response to lipopolysaccharide or LPS (pro-
inflammatory) and IL-4 (anti-inflammatory) (Mullican et al., 2011). Thus, HDAC3 
could potentially be the convergent integrator of pathogenic stimuli to orchestrate 
well-balanced inflammatory responses. Taking advantage of this innate immune 
system model, we wish to understand the mechanism that enables HDAC3 to 
“switch” between its enzymatic states and confer differential transcriptional 
consequences, as HDAC3 was associated with both hyper- and hypo-acetylated 
genomic regions (Chen et al., 2012). Such knowledge will not only shed light on 
how HDAC3 dynamically functions as the integrator of external signal to the 
immune system, but also contribute to the ever-growing complexity of HDAC3-
mediated transcriptional regulatory mechanisms. 
Endotoxic shock, or sepsis, is an immune-mediated dysregulation results 
from severe systemic inflammatory response commonly induced by bloodstream 
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infection with gram-negative bacteria. The pathophysiology of this deadly disease 
is poorly understood as definitive metrics to predict or determine why or whether a 
particular patient will develop sepsis or respond to medical treatment remain 
elusive. What we do understand, however, is that the sudden onset of multi-organ 
failures initiated by an infection that would otherwise be non-lethal results from the 
inappropriate hyperactivation of the innate immune system that produce a massive 
amount of inflammatory cytokines that overwhelm the body, leading to increased 
vascular permeability due to endothelial dysfunction and the consequential barrier 
disruption, eventually leading to severe hypotension, multi-organ dysfunctions and 
mortality (Gyawali et al., 2019). Interestingly, a similar phenomenon has been 
reported in patients infected with SARS-CoV2, the virus responsible for the 
pandemic that wreaked havoc globally in 2020 (Remy et al., 2020; Varga et al., 
2020). Worldwide, over 5 million children die from sepsis each year. In the United 
States, sepsis is the third leading cause of death only after heart disease and 
cancer. There are over 1.6 million cases of sepsis every year, with a 20% mortality 
rate (Torio et al., 2016; Mayr et al., 2017). Needless to say, it is of paramount 
importance that we gain deeper insights, especially with regards to the role of 
HDAC3, into not only the pathophysiology of this illness, but also reliable 








To determine whether HDAC3 has deacetylase (DA)-independent 
functions, we utilized bone-marrow derived macrophages (BMDM) with myeloid-
specific deletion of HDAC3 (MHD3KO) that were cultured in vitro after retrovirally-
mediated expression of empty control vector, the catalytically-dead Y298F mutant, 
or wild-type HDAC3 (WT-rescue) (Mullican et al., 2011; Sun et al., 2013).  Y298F 
expression was titrated such that both the mRNA (Fig. 3.1a) and the protein (Fig. 
3.1b) levels were comparable to that of endogenous HDAC3. Deacetylase activity 
of immunoprecipitated HDAC3 from Y298F-expressing cells was markedly 
reduced, to a level indistinguishable from that of MHD3KO macrophages (Fig. 
3.1c).  
We next investigated the role of HDAC3 catalytic activity in the 
transcriptional response to acute LPS challenge in vitro. As expected, LPS induced 
massive changes, with up-regulation of classic inflammatory markers such as Il6, 
Il1a, Il1b, and Nos2, and approximately one-third of LPS-stimulated differentially 
expressed genes (762/2152) were lost in the MHD3KO macrophages (Fig. 3.1d). 
Importantly, principle component and correlational analyses of BMDM from 
Control, HDAC3KO, Y298F, and WT-rescue transcriptional profiles revealed that   
the majority of variance comes from LPS stimulation, demonstrating clear 
distinction between treated and untreated groups (85.5% of variance). Differences 
within the treated and untreated groups were much less significant across 
genotypes (7%), suggesting that the different experimental groups were well 
controlled for variations introduced during in vitro differentiation and viral 
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transduction (Extended Data Figs. 3.1a-c). It should be noted that the 
transcriptome of MHD3KO macrophages may be biased towards an alternative 
(M2-like) phenotype, which may affect the expression of LPS-inducible genes. 
Nevertheless, more than half of the HDAC3-dependent, LPS-responsive genes 
(385/762) were rescued by the Y298F mutant (referred to hereafter as DA-
independent genes) and were highly overlapped with control and WT-rescue 
macrophages (Extended Data Fig. 3.1d).  
We particularly focused on the 174 genes, including Il6 and Il1a that were 
upregulated by LPS in an HDAC3-dependent, but enzyme-independent manner 
(Fig. 3.1e). These exhibited a pro-inflammatory profile, including cytokine 
production and activation of NF-κB signaling (Fig. 3.1f). By contrast, the 142 
HDAC3-dependent LPS-downregulated genes that failed to be rescued by the 
Y298F mutant (Extended Data Figs. 3.1e-f, referred to hereafter as DA-
dependent genes), were functionally most notable for down-regulation of TLR 
signaling, including Tlr4 gene transcription (Extended Data Fig. 3.1g), suggesting 
a potential negative feedback mechanism in endotoxin response (Marinelli et al., 
2015). Overall, the Y298F mutant phenocopied the wild-type HDAC3 inflammatory 
transcriptional response to LPS stimulation, while the transcriptional response to 
the anti-inflammatory cytokine IL4 was enzyme-dependent (Extended Data Fig. 
3.1h), indicating that the enzyme-independent activity of HDAC3 was highly 
specific to the LPS response.  
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To understand the mechanisms underlying the DA-independent and DA-
dependent transcriptomes, we performed chromatin-immunoprecipitation followed 
by high-throughput sequencing (ChIP-seq) for HDAC3. All ChIP-seq experiments 
were performed with three biological replicates that showed a high degree of 
mutual correlation, and that we could establish high-confidence HDAC3 genomic 
binding sites by comparing results between control and HDAC3 KO macrophages 
(Extended Data Figs. 3.2a and 3.2b). LPS stimulation significantly increased 
HDAC3 genomic occupancy within 100 kilobases (kb) of transcription start sites of 
previously identified DA-independent genes (Fig. 3.2a), whereas HDAC3 binding 
was unchanged near DA-dependent genes (Fig. 3.2b). These results suggest that 
activation of DA-independent genes might results from specific recruitment of 
HDAC3 to these loci by LPS. 
We next assessed the functionality of HDAC3 binding sites using two 
independent measures of enhancer activity, namely Global Run-On sequencing 
(GRO-seq) and acetylated histone H3 lysine 27 (H3K27Ac) ChIP-seq. Globally, 
neither loss of HDAC3 nor LPS stimulation perturbed enhancer RNA (eRNA) 
production (Extended Data Fig. 3.2c) or H3K27Ac levels (Extended Data Figs. 
3.2d and 3.2e). However, at HDAC3 binding sites near DA-independent genes, 
LPS stimulated a marked increase in eRNA production (Fig. 3.2c and Extended 
Data Fig. 3.2f) as well as H3K27Ac levels (Fig. 3.2d), which were attenuated in 
the MHD3KO. Conversely, enhancer activity (Fig. 3.2e and Extended Data Fig. 
3.2g) and H3K27Ac abundance (Fig. 3.2f) proximal to DA-dependent genes were 
reduced by LPS stimulation and considerably induced upon loss of HDAC3, 
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consistent with HDAC3 function as a repressor via histone deacetylation at these 
sites. Although functional enhancers may not always regulate the nearest genes 
(Gasperini et al., 2019), the transcriptional congruity between HDAC3-regulated 
enhancers and HDAC3-regulated genes supports a direct enhancer-promoter 
regulatory relationship.  
Since HDAC3 does not have intrinsic DNA binding capability, we 
considered whether the selective engagement of its catalytic activity was 
determined by transcription factors that facilitate genomic recruitment. De novo 
motif exploration of HDAC3-bound LPS-stimulated enhancers expectedly revealed 
the canonical motifs bound by the macrophage lineage determinant PU.1 and by 
NF-kB-p65 (Extended Data Fig. 3.2h). Application of a machine learning-based 
transcription factor binding analysis (TBA) (Fonseca et al., 2019) to DA-
independent and DA-dependent HDAC3-bound genomic regions revealed that 
DNA-sequence features intrinsic to these distinct genomic regions could predict 
different outcomes (Extended Data Fig. 3.3a). Specifically, TBA identified ATF2 
as the most statistically significant positive cobinding-partner at DA-independent 
sites, while ATF3 was predicted to be the transcription factor most likely 
responsible for the outcome of DA-dependent genes (Fig. 3.3a). Interestingly, 
ATF2 was predicted to be negatively correlated with HDAC3 binding at DA-
dependent sites while ATF3 might negatively influence the binding of HDAC3 at 
DA-independent sites (Fig. 3.3a). These results were also confirmed by an 
independent approach using HOMER to identify differential enrichment of ATF2 
and ATF3 motifs at DA-independent and DA-dependent sites, respectively (Fig. 
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3.3b). Motifs recognized by the AP-1 superfamily of Jun, Fos, JDP, and ATF 
transcription factors include the cAMP-response element (CRE) variant, an 
octamer with a three-nucleotide sequence palindromically flanking two central 
nucleotides (TGACGTCA), and the TPA-response element (TRE) variant, 
comprised by the same palindrome with only a single central nucleotide 
(TGAGTCA). Intriguingly, no other AP-1 family members displayed the same 
robust differential binding affinity at DA-independent sites as ATF2, and at DA-
dependent sites as ATF3 (Extended Data Figs. 3.3b-c). Moreover, HDAC3-bound 
eRNAs were more abundantly transcribed when the region contained the ATF2 
motif than ATF3 (Extended Data Fig. 3.3d). 
To test whether these predicted motifs were sufficient to differentially 
determine the engagement of HDAC3 catalytic activity for transcription, we 
transfected macrophages with reporter genes consisting of enhancer elements 
upstream of either Clec2d, a DA-independent gene containing the ATF2 motif 
(Extended Data Fig. 3.3e), or Gas6, a DA-dependent gene containing the ATF3 
motif (Extended Data Fig. 3.3f). We arrived at these representative enhancer 
elements through an unbiased approach by identifying the consensus sequences 
for 171 and 142 DA-independent and -dependent sites, with Clec2d and Gas6 
enhancer elements mapping best to the consensus sequences of the respective 
sites. LPS markedly stimulated the transcriptional activity of the ATF2 reporter in 
an HDAC3-dependent manner, which was rescued by the Y298F, only in the 
presence of endogenous ATF2, and independent of ATF3 (Extended Data Fig. 
3.3g). Moreover, mutating the ATF2 motif to ATF3 motif abrogated the LPS-
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stimulated induction of luciferase transcription (Extended Data Fig. 3.3g). By 
contrast, the ATF3 reporter had strong basal activity that was repressed by LPS in 
an HDAC3-dependent manner that was only rescued by catalytically active WT 
HDAC3, and unaffected by depletion of ATF2 (Extended Data Fig. 3.3h). 
However, loss of either ATF3 or the ATF3 binding motif de-repressed luciferase 
transcription, phenocopying loss of HDAC3 (Extended Data Fig. 3.3h). These 
results suggest a direct relationship between ATF2/ATF3 binding and downstream 
transcriptional outcomes. 
These results predicted that ATF2 would be more abundant at DA-
independent HDAC3-regulated sites while ATF3 would be preferentially 
associated with enzyme-active HDAC3, and this was borne out by comparison of 
their respective cistromes (Extended Data Fig. 3.4a). ATF2 was more abundant 
at DA-independent HDAC3-regulated sites in LPS-treated macrophages (Fig. 
3.3c), while ATF3 was more enriched at HDAC3-bound sites near DA-dependent 
genes (Fig. 3.3d). Depletion of ATF2 or ATF3 with multiple independent siRNAs 
(Extended Data Figs. 3.4b-c) did not induce significant transcriptional changes at 
baseline (Extended Data Fig. 3.4d). However, loss of ATF2, but not ATF3, 
reduced HDAC3 recruitment (Fig. 3.3e and Extended Data Fig. 3.4e) and 
specifically abolished HDAC3 DA-independent transcriptional activation of LPS-
induced genes (Fig. 3.3f). In contrast, loss of ATF3, but not ATF2, specifically 
diminished HDAC3 recruitment to DA-dependent enhancers (Fig. 3.3g and 
Extended Data Fig. 3.4f), resulting in de-repression of LPS-downregulated genes 
(Fig. 3.3h). These results suggest that differences in the enrichment of ATF2 and 
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ATF3 genomic occupancy determine the dichotomous functions of HDAC3 
transcriptional regulation in the response to LPS. 
To gain insight into the mechanism of ATF2-mediated transcriptional 
activation by HDAC3, we performed cistromic profiling for p65, which has been 
previously implicated in HDAC3-dependent LPS signaling (Barish et al., 2010; 
Chen et al., 2018; Ziesche et al., 2012) and whose motif was enriched at HDAC3-
bound enhancers. LPS induced genomic binding of p65 at DA-independent sites 
(Extended Data Fig. 3.4g) more robustly than at DA-dependent sites (Extended 
Data Fig. 3.4h). p65 binding was enhanced by the loss of HDAC3 only at DA-
dependent sites (Extended Data Fig. 3.4h), consistent with literature showing that 
p65 is a direct substrate of HDAC3 (Ziesche et al., 2012; Chen et al., 2001; Kiernan 
et al., 2003) and that deacetylation triggers the nuclear export of p65 (Chen et al., 
2001; Kiernan et al., 2003). p65 depletion did not alter HDAC3 genomic binding 
(Figs. 3.3e and 3.3g), but attenuated the LPS-induction of DA-independent genes 
(Fig. 3.3f) without affecting DA-dependent genes (Fig. 3.3h), suggesting a specific 
role for p65 recruitment in DA-independent activation of pro-inflammatory genes.  
As the catalytic activity of HDAC3 uniquely requires activation by co-
repressor complexes, we next tested whether the selective requirement of HDAC3 
deacetylase functions could be explained by differential recruitment of NCoR1/2. 
Strikingly, genomic colocalization of NCoR1/2 with HDAC3 was diminished at DA-
independent enhancers of genes activated by HDAC3 (Fig. 3.3i and Extended 
Data Fig. 3.4i) relative to their robust recruitment to DA-dependent targets that 
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were repressed by HDAC3 (Fig. 3.3j and Extended Data Fig. 3.4j). Quantitatively, 
NCoR1/2 were enriched at sites of ATF3 binding relative to ATF2 (Extended Data 
Figs. 3.4k-n), providing a plausible mechanism for the reported 
immunosuppressive functions of ATF3 (Khuu et al., 2007; De Nardo et al., 2014;  
Luo et al., 2015; Bambouskova et al., 2018),  including ATF3-dependent 
repression of Tlr4  (Luo et al., 2015;  Bambouskova et al., 2018; Labzin et al., 
2015). Conversely, the depletion of NCoR1/2 at ATF2/HDAC3 binding sites 
contributes to the physiological basis for DA-independent gene activation.  
We next tested the importance of HDAC3 DA-independent functions in 
regulating acute systemic inflammation. As we did not have much success in 
generating a Y298F knock-in mouse model, we utilized mice harboring reduced 
HDAC3 catalytic activity due to mutations in the deacetylase-activating domain 
(DAD) of NCoR1 and NCoR2 that abolish their activation of HDAC3 (NSDAD mice, 
You et al., 2013). At a dose of LPS that we empirically determined to be lethal to 
~50% of WT C57Bl6 mice within 24-120 hours (Extended Data Fig. 3.5a), NSDAD 
mice succumbed within 28 hours of LPS injection (Fig. 3.4a), similar to previous 
findings in NCoR1-DAD mutant mice (Yan et al., 2012). Correspondingly, 
circulating levels of pro-inflammatory cytokines IL6 and TNFa were markedly 
elevated in NSDAD mice 6 hours after LPS exposure (Extended Data Fig. 3.5b). 
By contrast, MHD3KO were largely protected from acute endotoxin lethality (Fig. 
3.4a), with reduced circulation of pro-inflammatory cytokines compared to control 
mice (Extended Data Fig. 3.5b). Thus, endogenous HDAC3 contributed to LPS 
susceptibility and this was magnified in the absence of its catalytic activity, 
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indicating that the DA-independent and DA-dependent functions of HDAC3 play 
opposing roles in LPS toxicity.  
To better understand the differential LPS sensitivities between MHD3KO 
and NSDAD mice, we evaluated the transcriptomes and HDAC3 cistromes of their 
peritoneal macrophages 6 hours after endotoxin exposure in vivo. Gene 
expression analysis (Extended Data Fig. 3.5c) demonstrated that the in vivo DA-
independent transcriptome was highly correlated with its in vitro counterpart 
(Extended Data Fig. 3.5d). Loss of HDAC3 protein abrogated the activation of 
LPS-stimulated DA-independent genes observed in both control and NSDAD mice 
(Fig. 3.4b and Extended Data Fig. 3.5e), and these bore the signature of the pro-
inflammatory response (Fig. 3.4c). By contrast, HDAC3 catalytic activity was 
required at in vivo DA-dependent genes (Extended Data Figs. 3.5f-g), where it 
exerted negative feedback on TLR4 signaling (Extended Data Fig. 3.5h). 
Moreover, as previously observed in vitro, LPS stimulated genomic recruitment of 
HDAC3 in vivo to sites near DA-independent genes (Extended Data Fig. 3.5i) but 
not DA-dependent genes (Extended Data Fig. 3.5j). Taken together, these results 
suggest that inhibition of HDAC3 catalytic activity might be detrimental due to 
persistent HDAC3-dependent activation of inflammatory gene expression that 
must be blunted to enhance survival (Copeland et al., 2005; Honore et al., 2019, 
Wheeler et al., 2008).  
Since HDAC inhibitors are used in the clinic for several therapeutic 
indications, we compared the effects of pharmacological and genetic inhibition of 
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HDAC3 catalytic activity on LPS toxicity. Consistent with previous reports of its 
anti-inflammatory benefits (Leoni et al., 2002; Roger et al., 2011; Lin et al., 2007, 
Hu and Mao, 2016), low doses of SAHA (25-100mg/kg) conferred a protective 
effect against severe septic shock (Extended Data Fig. 3.6a). This is opposite to 
the phenotype of the NSDAD mice in which HDAC3 protein is present without its 
deacetylase activity and may reflect the fact that SAHA is a more potent inhibitor 
of other class I HDACs than HDAC3 (Huber et al., 2011). By contrast, daily 
administration of a higher, yet non-toxic dose of SAHA (400 mg/kg) sensitized 
animals to LPS, similar to the phenotype of the NSDAD mice (Fig. 3.4d). MHD3KO 
mice subjected to the same treatment were protected (Fig. 3.4d), suggesting that 
genetic or pharmacological inhibition of HDAC3 enzymatic activity might sensitize 
animals to endotoxic shock through HDAC3-mediated hyperactivation of DA-
independent pro-inflammatory mediators. Indeed, the transcriptome of LPS-
treated macrophages treated with high dose SAHA was similar to that of 
macrophages from LPS-exposed NSDAD mice (Extended Data Fig. 3.6b). 
Moreover, this dose-dependent transcriptional activation was accompanied by 
LPS-stimulated HDAC3 recruitment to DA-independent genes (Extended Data 




In contrast to the lethality conferred by global loss of HDAC3, genetic 
inactivation of HDAC3 enzymatic activity through disruption of the deacetylase-
activating domain (DAD) of NCoR1 and NCoR2 is compatible with life with no overt 
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physiological abnormalities (You et al., 2013). Such evidence highlights the 
importance of HDAC3 non-enzymatic functions that remain poorly characterized 
and bear critical implications for the development of deacetylase-targeting drugs 
such as suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor that is FDA-
approved for the treatment of cancer and is being tested for efficacy in other 
diseases (Mann et al., 2007;  Gryder et al., 2012; De Souza et al., 2015;  Kazantsev 
et al., 2008;  Leoni et al., 2002). Deletion of HDAC3 diminishes the TLR4-mediated 
hyperinflammatory response to LPS in macrophages due to impaired activation of 
pro-inflammatory genes, but the mechanism is unknown (Chen et al., 2012). Here 
we identify a non-canonical mechanism whereby HDAC3 switches between its 
enzymatic states to contribute to both repression and activation of gene 
transcription in a single cell type. 
Though classically associated with transcriptional repression, a growing 
body of evidence suggests HDAC3 may also function as a coactivator (Chen et 
al., 2012; Greer et al., 2015; Lewandowski et al., 2015;  Emmett et al., 2017;  
Kuang et al., 2019). Here we have demonstrated selective enzymatic engagement 
of HDAC3 as a function of its differential association with co-repressor complexes 
NCoR1/2, selectively coordinated by either ATF3 or ATF2 (Fig. 3.4e). Our results 
implicate HDAC3 as a critical integrator of pathogenic stimuli to orchestrate well-
balanced inflammatory responses. Efforts to attenuate class I HDAC enzymatic 
activity for immunomodulation should carefully consider the paradoxical 
intensification of enzyme-independent, pro-inflammatory activities of HDAC3. 
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Our study confirms and helps explain previous reports of both inflammatory 
and anti-inflammatory roles of ATF2, ATF3, and HDAC3 (Bambouskova et al., 
2018; Chen et al., 2012; Yu et al., 2014). It remains to be determined how HDAC3 
recruitment to ATF2-bound enhancers structurally enhances HDAC3-p65 
interaction. “Substrate trapping” (Nalawansha et al., 2018) is an attractive 
hypothesis whereby the specificity of the complex DNA-protein interaction alters 
the enzymatic pocket. Alternatively, since HDAC3 is a stoichiometric component 
of the NCoR1/NCoR2 complexes, there could be either distinctive “pools” of 
HDAC3 that are dedicated to its dual functions or competitive inhibition of other 
interacting partners with NCoR1/NCoR2. 
Lastly, our findings significantly contributed to the already-complicated 
portfolios of regulatory activity exhibited by HDAC3. If we break HDAC3 functions 
into whether it acts as a repressor or activator, and whether or not deacetylase 
activity is required, we will find that HDAC3 has been shown to work in the 
circadian clock as a suppressor with it deacetylase activity, but can also repress 
transcription in the absence of deacetylase activity. Moreover, HDAC3 was also 
shown to be important in activating crucial genes regulating core body temperature 
in the brown adipose tissue as well as the intestinal microbiome with its 
deacetylase activity. The current study helps “fills in the blank” by implicating the 
deacetylase-independent function of HDAC3 that overrides the innate immune 
response through hyper-activation of inflammatory cytokines, leading to increased 




Figure 3.1 | HDAC3 activates LPS-stimulated inflammatory gene expression in a deacetylase (DA)-
independent manner. (a) Hdac3 mRNA levels in control, MHD3KO, Y298F rescue, and WT rescue
macrophages as quantitated by qRT-PCR. Data shown mean ± sd (n = 6 biological replicates), p values
calculated by one-way ANOVA. (b) Western Blot (performed independently twice, n = 3 biological replicates) of
HDAC3 protein levels in control, MHD3KO, Y298F rescue, and WT rescue macrophages, with Vinculin as
loading control. (c) Deacetylase activity of HDAC3 immunoprecipitated from control, MHD3KO, Y298F rescue,
and WT rescue macrophages as measured by fluorescent signal from enzymatically cleaved substrate. Data
shown mean ± sd (n = 3 biological replicates). p values calculated by one-way ANOVA. (d) Scatterplot of RNA-
seq data showing transcripts-per-kilobase-million (TPM)-transformed average read counts from vehicle or LPS-
treated control macrophages (n = 4 biological replicates, TPM > 0.1) and HDAC3-regulated LPS-responsive
genes (up: pink, down: light blue; differential expression (DE) cutoff: |log2FC| > 1, two-sided BH-adjusted FDR <
0.05, as determined by edgeR likelihood ratio test). Deacetylase-independent (red enclosed circle) are genes
whose LPS-stimulated changes were rescued by Y298F and wild-type HDAC3. Deacetylase-dependent (blue
enclosed circle) are genes whose LPS-stimulated changes were rescued by wild-type HDAC3 but not by Y298F.
(e) Heatmap showing 174 LPS-upregulated, HDAC3-dependent differentially expressed genes that were
rescued by Y298F and wild-type HDAC3 (DA-independent genes: n = 4 biological replicates, DE cutoff: |log2FC|
> 1, two-sided BH-adjusted FDR < 0.05 as determined by edgeR likelihood ratio test). (f) Gene ontology analysis
of 174 LPS-upregulated DA-independent genes (n = 4 biological replicates). q-values represent BH-adjusted








Extended Data Figure 3.1| Deacetylase (DA)-independent and –dependent functions of HDAC3 in the
inflammatory response to LPS. (a) Scatterplots of RNA-seq experiments in control, MHD3KO, Y298F, and
WT-rescue, with or without LPS, showing correlation between biological replicates using either log2
transformation (log2(x+1)), variance stabilizing transformation (vst), or regularized-logarithm transformation
(rlog) of normalized read counts. (b) Principle component analysis (PCA) plot using the vst values from RNA-
seq experiments in control, MHD3KO, Y298F, and WT-rescue BMDM, with or without LPS (n = 4 biological
replicates). (c) Heatmap of sample-to-sample distances using the vst values from RNA-seq experiments in
control, MHD3KO, Y298F, and WT-rescue, with or without LPS (n = 4 biological replicates). (d) Empirical
cumulative distribution function (CDF) and associated two-sided K-S test D-statistics of LPS-stimulated changes
in statistically-modeled DA-independent gene expression (385 genes) for control, MHD3KO, Y298F, and WT-
rescue (n = 4 biological replicates). (e) Empirical CDF and associated two-sided K-S test D-statistics of LPS-
stimulated changes in statistically-modeled DA-dependent gene expression (377 genes) for control, MHD3KO,
Y298F, and WT-rescue (n = 4 biological replicates). (f) Heatmap showing 142 LPS-down-regulated genes that
were rescued by wild-type HDAC3 but not by Y298F (DA-dependent genes: n = 4 biological replicates, DE
cutoff: |log2FC| > 1, two-sided BH-adjusted FDR < 0.05 as determined by edgeR likelihood ratio test). (g) Gene
ontology analysis of 142 LPS-down-regulated genes (n = 4 biological replicates). q-values represent BH-
adjusted one-sided hypergeometric p-values for over-representation as determined by Enrichr. (h) LPS-
stimulated (762 genes) and IL4-stimulated (405 genes) transcriptomic correlation of MHD3KO and Y298F,
compared to control BMDM (n = 4 biological replicates). Heatmap showing Spearman’s correlation rho values




Figure 3.2 | Differential recruitment and transcriptional functions of HDAC3 at Deacetylase (DA)-
independent and –dependent LPS-responsive genes. (a,b) Average density profiles in reads-per-million
(RPM) of HDAC3 ChIP-seq showing mean ± se (n = 3 biological replicates) at enhancers near (a) DA-
independent genes (two-sided Wilcoxon’s p = 2.6e-15) or (b) DA-dependent genes (two-sided Wilcoxon’s p =
0.084) in vehicle or LPS treated BMDM. (c,d) Average density profiles in RPM showing mean ± se (n = 3
biological replicates) of (c) bidirectional eRNA transcription measured by GRO-seq (Control LPS vs. MHD3KO
LPS two-sided Wilcoxon’s p = 7.7e-25) or (d) H3K27Ac levels measured by ChIP-seq (Control LPS vs.
MHD3KO LPS two-sided Wilcoxon’s p = 4.2e-7) at HDAC3-bound sites near DA-independent genes in control
and MHD3KO BMDM, with or without LPS. (e,f) Average density profiles in RPM showing mean ± se (n = 3
biological replicates) of (e) bidirectional eRNA transcription measured by GRO-seq (Control LPS vs. MHD3KO
LPS two-sided Wilcoxon’s p = 3.2e-126) or (f) H3K27Ac levels measured by ChIP-seq (Control LPS vs.
MHD3KO LPS two-sided Wilcoxon’s p = 6.4e-12) at HDAC3-bound sites near DA-dependent genes in control








Extended Data Figure 3.2 | Differential recruitment and enhancer activity of HDAC3 at LPS-responsive
genes. (a) Scatterplots of ChIP-seq experiments for HDAC3 and H3K27Ac in vehicle or LPS-treated control
BMDM (n = 3 biological replicates) showing correlation between biological replicates using tag counts per base-
pair (TPB) at identified peak regions. Pearson’s p-values were calculated with two-sided t-tests. (b) Average
density profiles in RPM of HDAC3 ChIP-seq showing mean ± se (n = 3 biological replicates) at all identified
HDAC3 peaks (10966 total) in control and MHD3KO macrophages, with or without LPS. (c) Average density
profiles in RPM of GRO-seq showing mean ± se (n = 3 biological replicates) at all identified eRNAs (12192 total)
in control and MHD3KO BMDM, with or without LPS. (d) Average density profiles in RPM of H3K27Ac showing
mean ± se (n = 3 biological replicates) at all identified H3K27Ac peaks (50247 total) in control and MHD3KO
macrophages, with or without LPS. (e) Western Blot (performed independently twice) of HDAC3 and H3K27Ac
protein levels in control and MHD3KO macrophages, with Vinculin and Histone H3 as loading controls. (f,g)
Genome-browser tracks showing three biologically replicated examples of enhancer and gene body activity as
measured by GRO-seq relative to HDAC3 ChIP-seq peaks in control and MHD3KO macrophages, with or
without LPS near (f) DA-independent or (g) DA-dependent genes. (h) Top de novo enriched motifs at HDAC3-
bound genomic regions (10966 sites from n = 3 biological replicates). Statistics was determined by HOMER with




Figure 3.3 | Engagement of HDAC3 enzyme activity is determined by its differential recruitment by ATF2
and ATF3. (a) Machine learning-based transcription factor binding analyses (TBA) applied to HDAC3-bound
200bp genomic regions (n = 3 biological replicates) near DA-independent and DA-dependent genes. DNA motifs
are ranked based on binding coefficient (negative or positive correlation with HDAC3 binding) and significance of
the motifs based on likelihood ratio test. (b) Differential enrichment of TGACGTCA (ATF2 motif 44/172
independent, 0/141 dependent) or TGACTCA (ATF3 motif 24/172 independent, 97/141 dependent) motif at
HDAC3-bound sites near DA-independent and DA-dependent genes. (c,d) Average density profiles in RPM of
(c) ATF2 (two-sided Wilcoxon’s p = 3.6e-19) and (d) ATF3 (two-sided Wilcoxon’s p = 1.9e-10) ChIP-seqs
showing mean ± se (n = 3 biological replicates) at HDAC3-bound sites near either DA-independent or DA-
dependent genes in LPS-treated control BMDM. (e,g) Average density profiles in RPM of HDAC3 ChIP-seq
showing mean ± se (n = 2 biological replicates) for control (siC), ATF2-depleted (siAtf2), ATF3-depleted (siAtf3),
or p65(Rela)-depleted (si-p65) LPS-treated BMDM at HDAC3-bound sites near (e) DA-independent or (g) DA-
dependent genes. (f,h) Heatmap showing LPS-induced transcriptional changes as a function of Log2Foldchange
(log2FC) comparing LPS-treated and vehicle control (n = 3 biological replicates) of (f) DA-independent or (h) DA-
dependent genes in control, MHD3KO, Y298F, ATF2-depleted (siAtf2), ATF3-depleted (siAtf3), or p65-depleted
(si-p65) BMDM. (i,j) Heatmaps of input, HDAC3, NCoR1, and NCoR2 ChIP-seq showing average signal (n = 3
biological replicates) in RPM at HDAC3-bound sites near (i) DA-independent or (j) DA-dependent genes. DA-
independent sites = 172, DA-dependent sites = 141.
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Extended Data Figure 3.3 | ATF2 and ATF3 differentially mediate HDAC3 transcriptional effects at DA-
independent and DA-dependent sites, respectively. (a) Comparison of the performance of TBA classifiers
modeled against DA-independent and DA-dependent 200bp-DNA sequences as measured by the area under
the receiver operating characteristic curve (auROC, n = 5 independent train-test iterations, data shown mean ±
sd). (b) Heatmap showing relative enrichment of several AP-1 family member DNA motifs as determined by TBA
with likelihood ratio test against DA-independent and DA-dependent 200bp-DNA sequences across 5 train-test
iterations. The non-redundant, merged motifs from TBA include ATF1,4,5,6,7, Jun family, Fos family, and other
related bZIP factors. (c) Average density profiles in RPM of Fos, JunB, JunD, and CREB ChIP-seqs obtained
from GEO database at HDAC3-bound sites near either DA-independent or DA-dependent genes in LPS-treated
BMDM. (d) Average density profiles in RPM of bidirectional eRNA transcription measured by GRO-seq showing
mean ± se (n = 3 biological replicates) at HDAC3-bound enhancers with ATF2 motif (1680 sites) or ATF3 motif
(3673 sites) (two-sided Wilcoxon’s p = 8.6e-127) in LPS-treated BMDM. (e,f) Genome-browser tracks showing
HDAC3, ATF2, and ATF3 ChIP-seq peaks at enhancer elements upstream of (e) Clec2d or (f) Gas6, as well as
gene body activity as measured by RNA-seq in control, MHD3KO, Y298F, and WT rescue macrophages, with or
without LPS. (g,h) Dual-luciferase assays of transcription driven by the (g) Clec2d or (h) Gas6 enhancers in
control, MHD3KO, Y298F rescue, WT rescue (WT), ATF2-depleted, and ATF3-depleted BMDM, with or without
LPS stimulation. Data shown mean ± sd, n = 4 biological replicates. p values were calculated by one-way








Extended Data Figure 3.4 | ATF2 and ATF3 recruit HDAC3 to sites near DA-independent and DA-
dependent genes, respectively. (a) Scatterplots of ChIP-seq experiments for ATF2, ATF3, NCoR1, NCoR2,
and p65 in LPS-treated BMDM (n = 3 biological replicates) showing correlation between biological replicates
using average tag counts per base-pair (TPB) at identified peak regions. Pearson’s p-values were calculated
with two-sided t-tests. (b) Relative gene expression levels of Atf2, Atf3, and p65 (Rela) as measured by qRT-
PCR in control (siC), ATF2-depleted (siAtf2), ATF3-depleted (siAtf3), or p65-depleted (si-p65) BMDM (n = 3
biological replicates). Data shown mean ± sd, p values calculated by two-sided Student’s t-test. (c) Western
Blots (performed once) of ATF2, ATF3, and p65 protein levels with Vinculin as loading control for control
(siControl), ATF2-depleted (siAtf2), ATF3-depleted (siAtf3), or p65-depleted (si-p65) BMDM, each with 3
independent siRNAs. (d) Heatmap of sample-to-sample distances using the vst values from RNA-seq
experiments in control (siC), ATF2-depleted (siAtf2), ATF3-depleted (siAtf3), or p65-depleted (si-p65) BMDM,
with or without LPS (n = 3). (e,f) Genome-browser tracks showing biologically replicated examples of HDAC3
ChIP-seq peaks in control (siControl), ATF2-depleted (siAtf2), ATF3-depleted (siAtf3), or p65-depleted (si-p65)
LPS-stimulated BMDM near (e) DA-independent or (f) DA-dependent genes. (g,h) Average density profiles in
RPM of p65 ChIP-seq showing mean ± se (n = 3 biological replicates) at HDAC3-bound sites near (g) DA-
independent genes (Control LPS vs. MHD3KO LPS two-sided Wilcoxon’s p = 0.063) or (h) DA-dependent genes
(Control LPS vs. MHD3KO LPS two-sided Wilcoxon’s p = 2.4e-16) in control and MHD3KO BMDM, with or
without LPS. (i,j) Box-and-whisker plot showing minimum, maximum, median, first quartile and third quartile
from quantification of average ChIP-seq signal (n = 3 biological replicates) in RPM for input, HDAC3, NCoR1,
and NCoR2 at HDAC3-bound sites near (i) DA-independent or (j) DA-dependent genes. p-values were
calculated with two-sided Mann-Whitney test. (k,l) Average density profiles in RPM showing mean ± se (n = 3
biological replicates) of (k) NCoR1 (two-sided Wilcoxon’s p = 4.7e-4) and (l) NCoR2 (two-sided Wilcoxon’s p =
1.2e-5) genomic colocalization with either ATF2 (19594 peaks) or ATF3 (n = 57041 peaks). (m,n) Genome-
browser tracks showing three biologically replicated examples of ChIP-seq peaks for HDAC3, ATF2, ATF3,
NCoR1, and NCoR2 in LPS-stimulated BMDM near (k) DA-independent or (l) DA-dependent genes. DA-




Figure 3.4 | Dichotomous functions of HDAC3 orchestrate the inflammatory response to endotoxin in
vivo. (a) Kaplan-Meier curves of control, MHD3KO, and NSDAD mice (n = 10 independent mice) subjected to
10 mg/kg of intraperitoneal injection of purified LPS. (#) p =0.014, (*) p = 0.024, (****) p = 7.1e-5, calculated by
two-sided Mantel-Cox’s test. (b) Heatmap showing 179 LPS-upregulated, HDAC3-dependent differentially
expressed genes in vivo that were rescued by NSDAD (DA-independent genes: n = 4 biological replicates,
except for KO veh and NSDAD LPS with n = 3 biological replicates, DE cutoff: |log2FC| > 1 , two-sided BH-
adjusted FDR < 0.05 as determined by edgeR likelihood ratio test). (c) Gene set enrichment analysis (GSEA) for
the in vivo DA-independent transcriptome (179 genes) showing enrichment of hallmark inflammatory response
genes that were more upregulated in peritoneal macrophages from LPS-treated control than LPS-treated
MHD3KO mice (n = 4 biological replicates). (d) Kaplan-Meier curves of control and MHD3KO mice subjected to
10mg/kg of intraperitoneal injection of purified LPS, with co-administration of either vehicle control (10% DMSO
in PBS, n = 8 independent mice) or 400mg/kg of SAHA (n = 9 independent mice. (#) p =0.0013 (**) p = 0.0014,
(***) p = 0.00052, calculated by two-sided Mantel-Cox’s test. (e) Dichotomous functions of HDAC3 orchestrate
the inflammatory response to endotoxin.
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Extended Data Figure 3.5 | Loss of HDAC3 protein but not deacetylase activity protects mice from acute
endotoxic shock. (a) Kaplan-Meier curves of wild-type C57Bl6 mice injected with increasing doses of LPS and
observed for 120 hours (n = 4 independent mice). (b) Serum cytokine concentrations measured by ELISA for IL6
and TNFα in 10 mg/kg LPS-injected control, MHD3KO, NSDAD, C57Bl6 mice (n = 5 independent mice)
administered with increasing doses of SAHA (25,100, 400mg/kg), and untreated control (n = 3 independent
mice). Data shown mean ± sd, p values calculated by one-way ANOVA. (c) PCA plot using the vst values from
RNA-seq experiments of in vivo peritoneal macrophages from control, MHD3KO, and NSDAD mice injected with
vehicle control (PBS) or 10mg/kg LPS (n = 4 biological replicates, except for KO veh and NSDAD LPS with n = 3
biological replicates). (d) Scatterplot showing correlation between in vitro (n = 4 biological replicates) and in vivo
(n = 3 biological replicates) DA-independent differential gene expression (174 genes). Pearson’s p-value was
calculated with two-sided t-test. (e) Empirical CDF and associated two-sided K-S test D-statistics of LPS-
stimulated changes in statistically-modeled DA-independent in vivo gene expression (251 genes) for peritoneal
macrophages from control (n = 4 biological replicates), MHD3KO (n = 4 biological replicates), and NSDAD (n = 3
biological replicates). (f) Heatmap showing 177 LPS-downregulated, HDAC3-dependent differentially expressed
genes in vivo that were not rescued by NSDAD (DA-dependent genes: n = 4 biological replicates, except for KO
veh and NSDAD LPS with n = 3 biological replicates; DE cutoff: |log2FC| > 1, two-sided BH-adjusted FDR < 0.05
as determined by edgeR likelihood ratio test). (g) Empirical CDF and associated two-sided K-S test D-statistics
of LPS-stimulated changes in statistically-modeled DA-dependent in vivo gene expression (404 genes) for
peritoneal macrophages from control (n = 4 biological replicates), MHD3KO (n = 4 biological replicates), and
NSDAD (n = 3 biological replicates). (h) Gene set enrichment analysis (GSEA) for the in vivo DA-dependent
transcriptome (177 genes) showing enrichment of KEGG Toll-like receptor signaling pathway that was more
upregulated in peritoneal macrophages from LPS-treated NSDAD mice (n = 3 biological replicates) than LPS-
treated control mice (n = 4 biological replicates). Bar graph showing Tlr4 gene expression level in normalized
counts of peritoneal macrophages from control and NSDAD treated with LPS. Data shown mean ± sd, two-sided
p value was calculated by Student’s t-test. (i,j) Average density profiles in RPM of HDAC3 ChIP-seq showing
mean ± se (n = 3 biological replicates) at HDAC3-bound sites near 167 in vivo (i) DA-independent genes (two-
sided Wilcoxon’s p = 1.7e-23) or (j) 165 DA-dependent genes (two-sided Wilcoxon’s p = 0.153) in peritoneal
macrophages from vehicle or LPS treated control mice.
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Extended Data Figure 3.6 | Dose-dependent effects of HDAC inhibitor SAHA on endotoxin susceptibility.
(a) Kaplan-Meier curves of C57Bl6 mice subjected to 10mg/kg of intraperitoneal injection of purified LPS, with
increasing doses of SAHA (25, 100, 400 mg/kg). SAHA vehicle (veh) = 10% DMSO in PBS. (*) p = 0.036, (**) p
= 0.001, (***) p = 0.00065, n = 10 independent mice, calculated by two-sided Mantel-Cox’s test. (b) Heatmap
showing LPS-induced transcriptional changes as a function of Log2Foldchange (log2FC) of 179 in vivo DA-
independent genes in LPS-exposed BMDM treated with increasing dose of SAHA (25, 100, 400nM, n = 3
biological replicates) and peritoneal macrophages from LPS-exposed MHD3KO (n = 4 biological replicates) and
NSDAD mice (n = 3 biological replicates). (c) Average density profiles in RPM of HDAC3 ChIP-seq showing
means of 3 biological replicates at HDAC3-bound sites near 172 DA-independent genes. (d) Genome-browser
tracks showing 3 biologically replicated examples of ChIP-seq peaks for HDAC3 in LPS-stimulated BMDM
treated with increasing dose of SAHA (25, 100, 400nM) near DA-independent genes. (e) Average density
profiles in RPM of HDAC3 ChIP-seq showing means of 3 biological replicates at HDAC3-bound sites near 141
DA-dependent genes. (f) Genome-browser tracks showing 3 biologically replicated examples of ChIP-seq peaks





Figure 4.5 | HDAC3 complex functional portfolio
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SUMMARY AND FUTURE DIRECTIONS 
 
In closing, there are three important conclusions that could be drawn from 
our studies: 1) HDAC3 is required to non-canonically activate transcription of pro-
inflammatory LPS-stimulated genes in an enzyme-independent manner; 2) 
Enzyme-independent activation of pro-inflammatory genes by HDAC3 sensitizes 
animals to endotoxic shock; 3) ATF2 recruits HDAC3 independently of NCoR1/2 
to deacetylase-independent genomic regions to activate transcription of pro-
inflammatory genes that are responsible for endotoxin susceptibility, while 
canonical HDAC3 deacetylase-dependent repression of transcription of TLR-
signaling genes in the presence of NCoR1/2 is mediated by ATF3.  
Conclusion 1: HDAC3 is required to non-canonically activate transcription of pro-
inflammatory LPS-stimulated genes in an enzyme-independent manner. We 
showed that deletion of HDAC3, blunted the activation of LPS-stimulated pro-
inflammatory genes both both in vivo and in vitro, and that this was rescued by 
reintroducing catalytically-inactive HDAC3 mutants. Furthermore, HDAC3 
recruitment to enhancers of these genes was specifically stimulated by LPS, and 
was required for upregulation of corresponding enhancer RNA (as well as 
increases in the levels of enhancer-associated H3K27Ac, a transcriptionally 
permissive histone mark that would otherwise be erased by active HDAC3 
enzymatic activity, supporting the notion that transcriptional regulation by HDAC3 
at these sites does not depend on canonical deacetylase function. Notably, we 
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showed that HDAC3 still exhibited canonical transcriptional repressive functions 
that requires enzymatic deacetylation at a distinct set of DA-dependent genes, 
both in vitro and in vivo. HDAC3 recruitment to these sites was required to 
suppress transcription of enhancer RNAs through deacetylation of H3K27Ac. 
These data strongly supported a novel mechanism of enzyme-independent 
transcriptional activation by HDAC3, in addition to its canonical role as a repressor. 
 Conclusion 2: Enzyme-independent activation of pro-inflammatory genes by 
HDAC3 sensitizes animals to endotoxic shock. This conclusion was supported by 
the demonstration that loss of HDAC3 allowed animals to better survive endotoxic 
challenge. Importantly, however, animals, with catalytic-inactive HDAC3 (NSDAD 
mice) were not protected, demonstrating that deacetylase-independent functions 
of HDAC3 were detrimental to the endotoxin response, and consistent with our 
conclusion that activation of pro-inflammatory genes was deacetylase-
independent. 
 Conclusion 3: ATF2 recruits HDAC3 independently of NCoR1/2 to deacetylase-
independent genomic regions to activate transcription of pro-inflammatory genes 
that are responsible for endotoxin susceptibility, while canonical HDAC3 
deacetylase-dependent repression of transcription of TLR-signaling genes in the 
presence of NCoR1/2 is mediated by ATF3. We arrived at ATF2 and 3 as 
candidates using an unbiased bioinformatic approach, and then performed 
numerous experiments to thoroughly test this mechanistic prediction. We observed 
robust enrichment of ATF2 at DA-independent sites (versus DA-dependent sites) 
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and showed that loss of ATF2 specifically reduced HDAC3 recruitment to these 
sites (phenocopying the loss of HDAC3. We further showed that NCoR1/NCoR2 
were not recruited to these sites, supporting the conclusion that HDAC3 functioned 
in an enzyme-independent manner at these sites. Conversely, HDAC3 recruitment 
to DA-dependent sites was computationally determined to be ATF3-mediated, and 
experiments bore out this mechanism: ATF3 ChIP-seq revealed enrichment at DA-
dependent sites to a much larger extent than DA-independent sites, loss of ATF3 
specifically resulted in reduction of HDAC3 recruitment at DA-dependent sites and 
transcriptionally phenocopied loss of HDAC3, and NCoR1/NCoR2 were recruited 
to these sites, providing robust mechanistic explanations for the enzyme-
dependent physiological roles of HDAC3 at these sites.  
Our extensive in vitro and in vivo studies support a previously unrecognized 
importance for HDAC3 in the inflammatory response to endotoxic shock. We 
provide strong evidence for dichotomous roles of HDAC3 in orchestrating 
inflammatory responses to pathogenic stimulus, including both deacetylase-
independent gene induction due to ATF2-mediated recruitment of HDAC3 in the 
absence of NCoR1/NCoR2 that are required for its catalytic activity, and 
deacetylase-dependent gene repression due to ATF3-mediated recruitment of 
HDAC3 along with the NCoRs. The discoveries of these physiological functions 
and the underlying mechanisms have important implications for therapy, and thus 
we believe that our findings will be of wide interest. 
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We were also perplexed by several observations that were made along 
the way that if followed up on in the future, would greatly expand the impact of 
our mechanistic studies: 
1. Interrogating HDAC3-independent NCoR1/NCoR2 genomic recruitment 
and transcriptional regulation 
In Chapter 3, we uncovered the physiological basis for the existence of 
HDAC3-enzyme independent function through dissecting genomic binding of its 
corepressor complexes, NCoR1 and NCoR2 and revealed that they were more 
enriched at sites where deacetylase function was required for gene repression 
than at genes where HDAC3 served to activate transcription. We further 
demonstrated that it was ATF2 that recruited HDAC3 to DA-independent sites, 
whereas ATF3 recruited HDAC3 to DA-dependent sites along with 
NCoR1/NCoR2. However, it remains unknown what recruits the corepressor 
complexes differentially to these distinct genomic regions. We hypothesized that 
ATF2/ATF3 might also differentially mediate NCoR1/NCoR2 binding as they did 
with HDAC3. To test this hypothesis, ChIP-seq for NCoR1/2 was performed in 
siRNA-mediated ATF2 or ATF3 knockdown cells. Surprisingly, the results showed 
that neither knockdown of ATF2 nor ATF3 affected NCoR1/2 recruitment (Fig. 
4.1a), suggesting that the corepressors are recruited through a different 
mechanism. Further analyses of the NCoR1/2 and HDAC3 cistromes revealed that 
indeed, NCoR1/2 have their own “lives”, independent of HDAC3, and of each 
other; that is: NCoR1 and NCoR2 occupy many genomic sites without HDAC3, 
and they also can bind DNA without each other (Fig. 4.1b). This demonstrates how 
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complex their regulatory relationship could be and that we only understand a small 
fraction of their diverse functional portfolios. These results are also consistent with 
unpublished findings from our lab that animals harboring loss of HDAC3, NCoR1, 
or NCoR2 in the brown adipose tissues present with completely distinct 
phenotypes in response to hypothermic challenge. Future efforts to delineate the 
shared and unique regulomes for HDAC3, NCoR1, and NCoR2 in tissue-specific 
single and double-knock out mouse models would help explain not only the 
observed phenotypic differences but also provide tremendous insights into how 
this “trifecta” regulates transcriptional machinery individually and in unison. Such 
knowledge would enrich our understanding of transcriptional repression and 
activation far beyond modulation of histone acetylation.  
 
2. Identification of HDAC3-regulated temporal response to endotoxic 
shock 
Inflammation is a product of evolution that allows higher organisms fight 
infection and survive injuries. It is a highly complex defense mechanism, including 
changes in blood flow and blood vessel permeability, and the migration of white 
blood cells (leukocytes) along with other protective components from the 
circulation to the site of tissue damage. When well-orchestrated, the inflammatory 
response should timely and precisely localize and eliminate the offending agent 
before subsiding to anti-inflammatory processes that help with the removal of 
damaged tissues so that the body can begin to heal and repair. It is the imbalance 
in this intricate rise-and-fall of inflammatory factors, the ying-and-yang of pro- and 
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anti-inflammatory mechanisms that underline the causes for many illnesses: 
cancer, diabetes, obesity, sepsis, and many other auto-immune diseases. In 
chapter 3, we implicated HDAC3 as the epicenter of the inflammatory response 
regulation, with its enzyme-independent function allowing for activation of pro-
inflammatory cytokines while the classical deacetylase function helps quench this 
battering cytokine storm through negative feedback on toll-like receptor signaling. 
It should logically follow that in order to mount an appropriate inflammatory 
response, the DA-independent “arm” of HDAC3 should be deployed first to activate 
the cytokine production and signaling cascade before the engagement of its 
catalytic activity at DA-dependent genes that would eventually help dampen this 
inflammatory influx and ensure tissue homeostasis. It would be of great interest 
and benefit to further delineate this potential temporal component of the HDAC3-
regulated innate immune response, not only to pinpoint the relative time point 
where the “switch” happens between the two arms of HDAC3 function, but also to 
discover the trigger to such alternative states. The therapeutic potentials 
uncovered from such findings could be tremendous. If we could manipulate the 
switch point between the HDAC3-regulated pro- and anti-inflammatory phases to 
our advantage; that is to either shorten the former to circumvent debilitating chronic 
inflammation or to lengthen it such that injurious agents (e.g. pathogens, 
cancerous cells) could be fought off more effectively, we could open doors to the 
next stage in the evolution of immunotherapy.  
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3. Identification of HDAC3 proteomic interactome and regulome in 
response to LPS by chromatin immunoprecipitation followed by mass-
spectrometry (ChIP-MS) 
Despite strong genomic localization of HDAC3 with ATF2 and ATF3 at DA-
independent and DA-dependent sites, respectively, it remains elusive whether 
HDAC3 interacts with these transcription factor at the protein-protein level. 
Previous attempts to detect these biochemical interactions have been 
unsuccessful due to the fact that the molecular weights of ATF2 and ATF3 coincide 
with the size of IgG heavy chain and light chain, respectively. To circumvent this 
technical challenge, we decided to use the HDAC3-3xFlag mouse model 
generated by Amy Hauck, a post-doc in the lab, to perform ChIP-MS to unbiasedly 
detect global interacting partner of HDAC3. Pilot results showed that HDAC3 could 
be pull-downed efficiently with anti-FLAG antibody from as little as 150 ug of input 
material (Fig.4.2). We are in the process of preparing the samples for mass-
spectrometry to learn more about the on-chromatin, protein-protein interactions 
that could be crucial in regulating HDAC3 functions. The results from this 
experiment would not only help confirm previous observations but also allow 
discovery of novel interactors that could be crucial roles in regulating HDAC3 
enzymatic activity in endotoxin response.  
4. Diet-induced reprogramming of liver epigenetic landscape and 
subsequent diet-induced isoform-switching 
In 2016, the prevalence of non-alcoholic steatohepatitis (NASH) and non-
alcoholic fatty liver disease (NAFLD), two of the deadliest yet silent diet-associated 
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liver diseases, are estimated at 12% and 34% of the population, respectively 
(Younossi et al., 2016).  NAFLD is growing to become the most common chronic 
liver condition in the Western population, further complicated by obesity and type 
2 diabetes (T2D) epidemics, while NASH is expected to increase by 63% in the 
next ten years (Aguiree et al.,2013). The damage caused by the modern high fat, 
high calorie western diet on the liver is indisputable, yet little is understood 
regarding the disease-causing changes at the genome level that occur over time 
as a function of exposure to overnutrition. Furthermore, both NASH and NAFLD 
exhibit tremendous heterogeneity with regards to onset, severity, and progression 
that challenges current diagnostic and therapeutic standards (Kim et al.,2013). 
Therefore, it is important to understand the series of events that trigger the initial 
‘downfall’ of once healthy hepatocytes. We believe that the liver epigenetic 
landscape could faithfully captures such changes, as epigenetic modifications are 
nature’s way of selecting for organisms that could dynamically and responsively 
adapt to environmental challenges. Combining our dual expertise in computational 
and experimental molecular biology, we seek to create an epigenetic atlas of high 
fat diet-induced changes in the liver of murine models, as well as identifying the 
associated transcriptional response that could explain the temporal deterioration 
of hepatocyte.  
As part of our preliminary experiments, we performed chromatin 
immunoprecipitation followed by sequencing (ChIP-seq) for several classic 
epigenetic marks: H32K27Ac, H3K9Ac, H3K27me3 as well as Pol II on liver of 
mice on high fat diet either for 4 weeks (short exposure) or 12 weeks (long 
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exposure) with corresponding normal chow diet control groups (n= 5 in each 
group). We observed an unexpected “switch” from a permissive, euchromatin-like 
state in acute exposure to a repressive, heterochromatin-like state in chronic 
exposure to high fat diet. As shown in Fig 4.3a, H3K27Ac, H3K9Ac, and Pol II 
signal, all associated with active transcription, decrease substantially genome-
wide, suggesting that the liver initially increase global gene production but later 
drastically reverse such primary response. Consistently, H3K27me3, classically 
associated with transcriptional suppression, demonstrated an opposite switch: low 
in early stage and high in long-term exposure. Functionally, downstream regulated 
genes are most notable for regulation of splicing (Fig 4.3b). We next investigated 
if the transcriptional landscape would mirror the changes occurs epigenetically.  
The transcriptional changes induced by HFD in acute exposure was also 
completely reverse after chronic exposure, suggesting a link between epigenetic 
changes and transcriptional changes (Fig 4.4). Most notably, Trem2 was identified 
as a target with the most prominent switch in isoform usage as a function of 
exposure to HFD (Fig 4.5). Of note, this gene has been previously implicated in 
the development of adipogenesis and obesity in mice (Park et al., 2015) 
 
In our future studies, we wish to further delineate this relationship by attempting to 
1) Establish a causal relationship between key epigenetic alternations and 
transcriptional modulations in the context of splicing, 2) Identify candidate genes 
that might govern such concerted response through creating genetic mouse 
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models, especially those that demonstrate drastic isoform usage switch, and 3) 
Build computational models that incorporate the observed changes to predict 
transcriptional response from heterogeneous input. We believe that these findings 
will enhance our understanding the sequential steps that occur as a function of 
high fat diet exposure, as well as open door for potential therapeutic option to 




Figure 4.1 | NCoR1 and NCoR2 have lives independent of HDAC3 and of each other. (a) Average density
profiles in normalized tag counts of NCoR1 and NCoR2 ChIP-seq at DA-independent or DA-independent sites in
control (siC), ATF2-depleted (siAtf2), or ATF3-depleted (siAtf3) BMDM. (b) Venn-diagrams showing overlaps
between HDAC3, NCoR1, and NCoR2 cistromes.
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Figure 4.2 | Detection of biochemical interaction between HDAC3 and partners using chromatin
immunoprecipitation followed by mass-spectrometry. Immunoprecipitation with Flag antibody to determine
































































Figure 4.3 | High fat diet-induced epigenetic changes. (a) Metagene analysis of epigenetic changes
measured by Pol II, H3K27Ac, H3K9Ac, and H3K27me3 level in liver tissues exposed to short (< 4 weeks) or
long (more than 6 weeks) period of high-fat diet. (b) Gene ontology analyses of genes with the most prominent
epigenetic changes.
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Figure 4.5 | Trem2 exhibits isoform-specific switching induced by exposure to HFD
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